https://www.ajmc.com/view/car-t-progress-global-submissions-for-kymriah-42-ongoing-response-with-yescarta-in-zuma1-patients-
CAR T Progress: Global Submissions for Kymriah, 42% Ongoing Response With Yescarta in ZUMA-1...
Oct 7, 2026 - A much-anticipated session on the second day of the 59th Annual Meeting and Exposition of the American Society of Hematology provided long-term updates on...
carprogressglobalsubmissionskymriah
https://pharmreviews.kz/novosti/novosti-eaes/po-pravilam-eaes-zaregistrirovan-preparat-car-t-kletochnoj-terapii-kymriah
По правилам ЕАЭС зарегистрирован препарат CAR-T-клеточной терапии Kymriah
Фармацевтическое обозрение Казахстана - издание для профессионалов сферы здравоохранения
carkymriah